Kidney Disease
Coverage of Kidney Disease in the Nexus archive.
- Rockwell Medical: Q2 Earnings Snapshot
Rockwell Medical Inc., a Michigan-based company, reported a loss of $1.2 million in its second quarter, or 34 cents per share. The maker of products for treating kidney disease and anemia posted revenue of $17.8 million during the period. Furthermore, Rockwell Medical expects full-year revenue to fall between $70 million and $75 million.
- STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study
Novo Nordisk's investigational drug ziltivekimab failed to reduce major heart events in a Phase 3 trial involving over 6,300 participants with heart disease, kidney disease, and inflammation, despite lowering inflammation markers. The company's shares fell about 7% following the announcement.
- Ask Dr. Nandi: What new guidelines could mean for how young adults manage 'bad' cholesterol
New guidelines expand statin eligibility to adults as young as 30, lowering cardiovascular risk thresholds and considering 30-year risk. A study estimates 21.5 million more Americans may qualify for statin therapy to prevent heart attacks or strokes, based on health data from 4,300 adults aged 30-79. The guidelines emphasize consulting doctors to assess individual risk factors like high LDL, diabetes, or family history.
- Firefighter donates kidney to husband, a fellow firefighter, after shocking diagnosis
Maddy Geer, a Phoenix firefighter, donated a kidney to her husband, Junior Coleman, a Surprise firefighter, after he was diagnosed with a rare kidney disease leading to stage 5 kidney failure. Both are recovering at home following surgery and aim to return to full duty. Coleman required dialysis three times weekly before the transplant, and the couple emphasized their gratitude for the successful procedure.
- Cyclosporiasis hospitalizes woman in Southfield
Ella Jones has been hospitalized in Southfield with a severe case of cyclosporiasis. Her kidney disease complicates the illness, making it deadly without treatment.
- Judge calls it illegal. It’s time for Tennesseans to call it immoral.
A Tennessee judge has deemed a state policy illegal, which forces 400 families with children having severe medical needs to choose between losing healthcare or facing immigration enforcement. The policy, linked to HB1710, has drawn criticism for its inhumane impact, particularly on families enrolled in Children’s Special Services.
- ‘I love life’: Wyandotte grandfather, football coach hopes living kidney donor will give him more time
Todd Sowards, a 58-year-old Wyandotte grandfather and football coach, is seeking a living kidney donor as his kidney disease progresses toward Stage 5 failure. His family is using local outreach and social media to find a donor, emphasizing the potential of paired donation programs to connect incompatible matches.
- Blood pressure medication recalled for potential ineffectiveness
The FDA recalled 11,460 bottles of chlorthalidone tablets due to potential ineffectiveness from failed dissolution specifications. The affected batches are RISA24001 (100-tablet bottles) and RISB24002 (1,000-tablet bottles), with an expiration date of April 2027. The medication is used to treat high blood pressure and fluid retention from conditions like heart failure, liver disease, kidney disease, or steroid treatments.
- Doctors calling on NHS to roll out urine test to catch life-threatening kidney disease cases early
Doctors are urging the NHS to implement a urine test for the early detection of life-threatening kidney disease. The test aims to identify cases at an earlier stage to improve treatment outcomes.
- Health chiefs issue urgent alert for Ramipril blood pressure and kidney disease medication: 'Check pack immediately'
Health chiefs have issued an urgent alert regarding the blood pressure and kidney disease medication Ramipril, urging patients to check their medication packs immediately.
- New blood test could identify heart and kidney disease years before people fall ill: Patients could benefit from life-changing early interventions
A new blood test can identify heart and kidney disease years before symptoms appear, allowing for early interventions that could change patients' lives. This breakthrough could lead to better patient outcomes and improved healthcare. The test enables timely medical interventions, potentially reducing the risk of severe illness.